A EV/EBITDA Analysis

Agilent Technologies' current EV/EBITDA of 23.4x means that for every dollar of its earnings before interest, taxes, depreciation, and amortization, investors are paying $23.40 of enterprise value—a measure of the company's total market value including debt.

This multiple sits above the healthcare sector median of 19.5x, placing it in the 76th percentile among peers, indicating a premium valuation relative to the industry. The metric has been completely stable over the past eight quarters, with a year-over-year change of 0.0% and a quarter-over-quarter change of 0.0%, showing no movement in either direction. The combination of a high, stable EV/EBITDA suggests that while the stock is priced at a premium compared to peers, the lack of upward drift implies the market has already baked in expectations without further expansion—so the risk of a multiple contraction is low, but the opportunity for multiple-driven gains is also limited. This stability and premium level are consistent with the NEUTRAL verdict, as there is no clear catalyst from the valuation trend to push the stock higher or lower, leaving it in a balanced position.

Frequently Asked Questions

Closest Sector Peers